Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT

Clinical trial NCT02728895 · COMPLETED

Trial details

NCT number: NCT02728895
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation

Start date: 2016-06-15
Primary completion: 2018-07-10
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.